Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Warfarin
Drug ID BADD_D02373
Description Warfarin is an anticoagulant drug normally used to prevent blood clot formation as well as migration. Although originally marketed as a pesticide (d-Con, Rodex, among others), Warfarin has since become the most frequently prescribed oral anticoagulant in North America. Warfarin has several properties that should be noted when used medicinally, including its ability to cross the placental barrier during pregnancy which can result in fetal bleeding, spontaneous abortion, preterm birth, stillbirth, and neonatal death. Additional adverse effects such as necrosis, purple toe syndrome, osteoporosis, valve and artery calcification, and drug interactions have also been documented with warfarin use. Warfarin does not actually affect blood viscosity, rather, it inhibits vitamin-k dependent synthesis of biologically active forms of various clotting factors in addition to several regulatory factors.
Indications and Usage For the treatment of retinal vascular occlusion, pulmonary embolism, cardiomyopathy, atrial fibrillation and flutter, cerebral embolism, transient cerebral ischaemia, arterial embolism and thrombosis.
Marketing Status Discontinued; Prescription
ATC Code B01AA03
DrugBank ID DB00682
KEGG ID D08682
MeSH ID D014859
PubChem ID 54678486
TTD Drug ID D0E3OF
NDC Product Code 50090-2582; 71610-462; 76282-329; 50090-2613; 51407-341; 51407-342; 43353-028; 70934-821; 51407-347; 43353-023; 65162-763; 70934-820; 76282-328; 65162-769; 71610-448; 50090-3263; 71335-1786; 70518-2816; 65162-762; 76282-333; 71335-1824; 70934-911; 43353-053; 50090-2654; 76282-335; 65162-764; 43353-029; 65162-766; 70518-2382; 50090-2936; 51407-348; 65162-767; 43353-054; 65162-761; 50090-2646; 43353-030; 51407-343; 51407-346; 70518-2381; 43353-021; 50090-2586; 70518-2717; 76282-334; 50090-5058; 76282-331; 71610-490; 71610-491; 76282-332; 43353-033; 71610-519; 65162-765; 50090-2645; 70934-587; 76282-327; 70518-2383; 65162-768; 51407-349; 70518-2395; 71335-1595; 50090-2617; 51407-344; 51407-345; 71610-458; 70518-2380; 70518-2394; 76282-330
Synonyms Warfarin | 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one | Apo-Warfarin | Aldocumar | Gen-Warfarin | Warfant | Coumadin | Marevan | Warfarin Potassium | Potassium, Warfarin | Warfarin Sodium | Sodium, Warfarin | Coumadine | Tedicumar
Chemical Information
Molecular Formula C19H16O4
CAS Registry Number 81-81-2
SMILES CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Coagulation time shortenedCytochrome P450 2C19P33261Not Available1109248; 806430; 1580446; 5006877; 806430; 5458032; 1109248; 15871634; 15487810; 15324521; 9200780; 624779; 12841813; 6690067; 3719899; 6499359
HaemorrhageCytochrome P450 2C9P11712T1924410073515; 11926893; 10961881
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Gait disturbance17.02.05.016; 08.01.02.002--
Gallbladder perforation12.01.02.005; 09.03.02.0020.000240%
Gangrene23.06.06.001; 11.02.01.003; 24.04.05.0030.000961%Not Available
Gastric cancer16.13.03.001; 07.21.02.001--Not Available
Gastric haemorrhage24.07.02.007; 07.12.01.0010.027330%
Gastric polyps16.05.03.001; 07.20.01.0030.000240%Not Available
Gastric ulcer07.04.03.0020.001922%
Gastric ulcer haemorrhage24.07.02.003; 07.04.03.0050.000901%Not Available
Gastritis07.08.02.0010.001382%
Gastritis erosive07.04.03.0030.000901%Not Available
Gastrooesophageal reflux disease07.02.02.003--
Gastroduodenal ulcer07.04.02.0050.000120%Not Available
Gastroenteritis viral11.05.04.005; 07.19.03.005--Not Available
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal haemorrhage07.12.02.001; 24.07.02.0090.032075%Not Available
Gastrointestinal necrosis24.04.08.006; 07.15.01.0030.000172%
Generalised tonic-clonic seizure17.12.01.002--Not Available
Gingival bleeding24.07.02.010; 07.09.07.0010.002222%Not Available
Glomerular filtration rate decreased13.13.01.009--Not Available
Glomerulonephritis rapidly progressive20.05.01.004; 10.04.04.0080.000047%Not Available
Gout15.01.06.001; 14.09.01.001--Not Available
Gravitational oedema02.05.04.014; 08.01.07.0050.000120%Not Available
Groin pain15.03.02.0040.000541%Not Available
Haemangioma24.03.06.004; 16.02.01.0020.000120%Not Available
Haemarthrosis24.07.01.046; 15.01.01.004; 12.04.03.0010.001922%Not Available
Haematemesis24.07.02.011; 07.12.02.0020.004865%Not Available
Haematochezia24.07.02.012; 07.12.02.0030.005346%Not Available
Haematocrit decreased13.01.05.0010.005526%Not Available
Haematocrit increased13.01.05.0020.000120%Not Available
Haematoma24.07.01.0010.019942%
The 10th Page    First    Pre   10 11 12 13 14    Next   Last    Total 37 Pages